(Q34455106)

2 August 2017

1 reference

title

Cerebrovascular structure and dementia: new drug targets (English)

1 reference

2 August 2017

0 references

Atkinson J

1

1 reference

2 August 2017

1 December 2001

1 reference

Trends in Pharmacological Sciences

2 August 2017

1 reference

2 August 2017

22

1 reference

2 August 2017

630-635

1 reference

2 August 2017

12

1 reference

The role of cerebral ischemia in Alzheimer's disease

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Are cerebrovascular factors involved in Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Cardiovascular factors in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Stroke, disability, and dementia: results of a population survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Chronic cerebrovascular ischemia in aged rats: effects on brain metabolic capacity and behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Cerebral microvascular pathology in aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Mild cognitive impairment represents early-stage Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Failure of cerebral autoregulation as a cause of brain dysfunction in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Effects of aging on mechanics and composition of cerebral arterioles in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Statins and the risk of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

The role of cholesterol in the biosynthesis of beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Effect of lovastatin on cerebral circulation in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Effects of an angiotensin-converting enzyme inhibitor and a beta-blocker on cerebral arterioles in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Effects of an angiotensin-converting enzyme inhibitor and a beta-blocker on cerebral arteriolar dilatation in hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Effects of long-term treatment with the calcium antagonist AE0047 on cerebrovascular autoregulation and hypertrophy in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Calcium antagonists decrease capillary wall damage in aging hypertensive rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

15-year longitudinal study of blood pressure and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Inhibition of amyloid formation: a strategy to delay the onset of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Mechanisms of beta-amyloid neurotoxicity: perspectives of pharmacotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Approaches to discovery and characterization of inhibitors of amyloid beta-peptide polymerization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Anti-inflammatory therapy for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Vascular nitric oxide may lessen Alzheimer's risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Aberrant expression of nitric oxide synthase III in Alzheimer's disease: relevance to cerebral vasculopathy and neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Monoamine oxidase-B inhibitors in the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Potassium channel openers prevent beta-amyloid toxicity in bovine vascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Effects of melatonin on rat pial arteriolar diameter in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Cerebral arteriolar structure and function in pinealectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Relationship between short-term and long-term blood pressure variabilities in essential hypertensives

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Are Alzheimer's disease, hypertension, and cerebrocapillary damage related?.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Beta amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium: usage of a novel blood brain barrier endothelial cell model system.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

A beta vasoactivity: an inflammatory reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

A beta vasoactivity in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Association of vascular amyloid beta and cells of the mononuclear phagocyte system in hereditary cerebral hemorrhage with amyloidosis (Dutch) and Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Hemodynamic changes during aging associated with cerebral blood flow and impaired cognitive function.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Beta-amyloid (1-42) peptide impairs blood-brain barrier function after intracarotid infusion in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Intravascular infusions of soluble beta-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

Cleavage of amyloid precursor protein elicited by chronic cerebral hypoperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901866-6

7 January 2021

10.1016/S0165-6147(00)01866-6

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11730973